JSF Financial LLC Decreases Position in Cardinal Health, Inc. $CAH

JSF Financial LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 30.0% in the 1st quarter, HoldingsChannel.com reports. The fund owned 6,612 shares of the company’s stock after selling 2,838 shares during the quarter. JSF Financial LLC’s holdings in Cardinal Health were worth $1,397,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of CAH. Norges Bank purchased a new position in Cardinal Health in the fourth quarter valued at $790,344,000. Wellington Management Group LLP raised its position in Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Marshall Wace LLP raised its position in Cardinal Health by 1,328.1% in the 4th quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after purchasing an additional 884,648 shares in the last quarter. Bessemer Group Inc. boosted its stake in shares of Cardinal Health by 7,053.4% in the 1st quarter. Bessemer Group Inc. now owns 750,038 shares of the company’s stock valued at $158,491,000 after buying an additional 739,553 shares during the period. Finally, SG Americas Securities LLC grew its position in shares of Cardinal Health by 3,829.1% during the fourth quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock worth $149,504,000 after buying an additional 708,995 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $225.76 on Tuesday. The stock has a fifty day moving average price of $217.11 and a 200 day moving average price of $213.94. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $243.21. The company has a market cap of $52.88 billion, a PE ratio of 34.52, a P/E/G ratio of 1.12 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts anticipate that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were issued a $0.5158 dividend. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 31.50%.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Evercore reduced their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Wells Fargo & Company reduced their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Morgan Stanley increased their target price on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Finally, UBS Group raised their price target on Cardinal Health from $260.00 to $274.00 and gave the company a “buy” rating in a research note on Monday. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $250.07.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.